Loading…
Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation
For the exploration of pharmacophoric moiety of malloapelta B (1) possessing the inhibitory activity of NF-kappaB activation, structural variation of alpha,beta-unsaturated carbonyl motif was attempted. 1 was reduced by catalytic hydrogenation, sodium borohydride, and lithium aluminumhydride. Cataly...
Saved in:
Published in: | Archives of pharmacal research 2006-10, Vol.29 (10), p.840 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 10 |
container_start_page | 840 |
container_title | Archives of pharmacal research |
container_volume | 29 |
creator | Van Luu, Chinh Van Chau, Minh Lee, Jung-Joon Jung, Sang-Hun |
description | For the exploration of pharmacophoric moiety of malloapelta B (1) possessing the inhibitory activity of NF-kappaB activation, structural variation of alpha,beta-unsaturated carbonyl motif was attempted. 1 was reduced by catalytic hydrogenation, sodium borohydride, and lithium aluminumhydride. Catalytic hydrogenation with 30 psi or 15 psi of H2 gas of 1 generated 8-butyl-5,7-dimethoxy-2,2-dimethylchroman (2) and 1-(5,7-dimethoxy-2,2-dimethylchroman-8-yl)butan-1-one (3), respectively. Reduction with sodium borohydride occurred at the double bond of alpha,beta-unsaturated ketone of 1 to give 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)butan-1-one (4). Reduction of 1 with lithium aluminumhydride and then quenched with methanol and water produced unexpected products, 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-methoxy-1-butene (5) and 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-hydroxy-l-butene (6). These are formed from the isomerization of initial product 9 through the continuous conjugate carbocation intermediate 11. Addition of ethylmagnesium bromide and dimethyl malonate anion to 1 gave the conjugate adducts 7 and 8. Ethylmagesium bromide and sodium borohydride reduction unusually gave the conjugate addition due to steric congestion around carbonyl group of 1. Compound 2 exhibits the reduced inhibitory activity against NF-kappaB activation and the others do not show the activity. Therefore alpha,beta-unsaturated carbonyl group of 1 should be important for its inhibitory activity. |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_17121177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17121177</sourcerecordid><originalsourceid>FETCH-LOGICAL-p547-31d34f6c091440e9988eecec94e8ac1c0c82523534d7a85684ccefb9a3e853c63</originalsourceid><addsrcrecordid>eNo1UMFOwzAUywHExuAXUH6gUtIkbXpk0wpI07j0Pr2mryzQNVGSou3vGWycbNmWLfmGzFmuRFbkRTUj9zF-MiYKpdQdmfGS55yX5Zwc10c_uADJupG6nmKMOCYLA40pTCZNAX_lAwyDA49DArqkvQs07ZHacW9bm1w4UTDJftt0Jh9gx5hos63PfjcZ7Oi2zr7Ae1heYn9jD-S2hyHi4xUXpKnXzeo127y_vK2eN5lXsswE74TsC8MqLiXDqtIa0aCpJGow3DCjc5ULJWRXglaFlsZg31YgUCthCrEgT5daP7UH7HY-2AOE0-7_AfEDbwpYyA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation</title><source>Springer Link</source><creator>Van Luu, Chinh ; Van Chau, Minh ; Lee, Jung-Joon ; Jung, Sang-Hun</creator><creatorcontrib>Van Luu, Chinh ; Van Chau, Minh ; Lee, Jung-Joon ; Jung, Sang-Hun</creatorcontrib><description>For the exploration of pharmacophoric moiety of malloapelta B (1) possessing the inhibitory activity of NF-kappaB activation, structural variation of alpha,beta-unsaturated carbonyl motif was attempted. 1 was reduced by catalytic hydrogenation, sodium borohydride, and lithium aluminumhydride. Catalytic hydrogenation with 30 psi or 15 psi of H2 gas of 1 generated 8-butyl-5,7-dimethoxy-2,2-dimethylchroman (2) and 1-(5,7-dimethoxy-2,2-dimethylchroman-8-yl)butan-1-one (3), respectively. Reduction with sodium borohydride occurred at the double bond of alpha,beta-unsaturated ketone of 1 to give 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)butan-1-one (4). Reduction of 1 with lithium aluminumhydride and then quenched with methanol and water produced unexpected products, 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-methoxy-1-butene (5) and 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-hydroxy-l-butene (6). These are formed from the isomerization of initial product 9 through the continuous conjugate carbocation intermediate 11. Addition of ethylmagnesium bromide and dimethyl malonate anion to 1 gave the conjugate adducts 7 and 8. Ethylmagesium bromide and sodium borohydride reduction unusually gave the conjugate addition due to steric congestion around carbonyl group of 1. Compound 2 exhibits the reduced inhibitory activity against NF-kappaB activation and the others do not show the activity. Therefore alpha,beta-unsaturated carbonyl group of 1 should be important for its inhibitory activity.</description><identifier>ISSN: 0253-6269</identifier><identifier>PMID: 17121177</identifier><language>eng</language><publisher>Korea (South)</publisher><subject>Alkaline Phosphatase - genetics ; Alkaline Phosphatase - metabolism ; Benzopyrans - chemistry ; Benzopyrans - pharmacology ; Cell Survival - drug effects ; Chromans - chemistry ; Chromans - pharmacology ; Euphorbiaceae - chemistry ; Female ; HeLa Cells ; Humans ; Hydrogenation ; Inhibitory Concentration 50 ; Magnetic Resonance Spectroscopy - methods ; Molecular Structure ; NF-kappa B - drug effects ; NF-kappa B - genetics ; NF-kappa B - metabolism ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - metabolism ; Spectrophotometry, Infrared - methods ; Time Factors ; Transfection ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; Tumor Necrosis Factor-alpha - pharmacology</subject><ispartof>Archives of pharmacal research, 2006-10, Vol.29 (10), p.840</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17121177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Luu, Chinh</creatorcontrib><creatorcontrib>Van Chau, Minh</creatorcontrib><creatorcontrib>Lee, Jung-Joon</creatorcontrib><creatorcontrib>Jung, Sang-Hun</creatorcontrib><title>Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation</title><title>Archives of pharmacal research</title><addtitle>Arch Pharm Res</addtitle><description>For the exploration of pharmacophoric moiety of malloapelta B (1) possessing the inhibitory activity of NF-kappaB activation, structural variation of alpha,beta-unsaturated carbonyl motif was attempted. 1 was reduced by catalytic hydrogenation, sodium borohydride, and lithium aluminumhydride. Catalytic hydrogenation with 30 psi or 15 psi of H2 gas of 1 generated 8-butyl-5,7-dimethoxy-2,2-dimethylchroman (2) and 1-(5,7-dimethoxy-2,2-dimethylchroman-8-yl)butan-1-one (3), respectively. Reduction with sodium borohydride occurred at the double bond of alpha,beta-unsaturated ketone of 1 to give 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)butan-1-one (4). Reduction of 1 with lithium aluminumhydride and then quenched with methanol and water produced unexpected products, 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-methoxy-1-butene (5) and 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-hydroxy-l-butene (6). These are formed from the isomerization of initial product 9 through the continuous conjugate carbocation intermediate 11. Addition of ethylmagnesium bromide and dimethyl malonate anion to 1 gave the conjugate adducts 7 and 8. Ethylmagesium bromide and sodium borohydride reduction unusually gave the conjugate addition due to steric congestion around carbonyl group of 1. Compound 2 exhibits the reduced inhibitory activity against NF-kappaB activation and the others do not show the activity. Therefore alpha,beta-unsaturated carbonyl group of 1 should be important for its inhibitory activity.</description><subject>Alkaline Phosphatase - genetics</subject><subject>Alkaline Phosphatase - metabolism</subject><subject>Benzopyrans - chemistry</subject><subject>Benzopyrans - pharmacology</subject><subject>Cell Survival - drug effects</subject><subject>Chromans - chemistry</subject><subject>Chromans - pharmacology</subject><subject>Euphorbiaceae - chemistry</subject><subject>Female</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Hydrogenation</subject><subject>Inhibitory Concentration 50</subject><subject>Magnetic Resonance Spectroscopy - methods</subject><subject>Molecular Structure</subject><subject>NF-kappa B - drug effects</subject><subject>NF-kappa B - genetics</subject><subject>NF-kappa B - metabolism</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Spectrophotometry, Infrared - methods</subject><subject>Time Factors</subject><subject>Transfection</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><issn>0253-6269</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNo1UMFOwzAUywHExuAXUH6gUtIkbXpk0wpI07j0Pr2mryzQNVGSou3vGWycbNmWLfmGzFmuRFbkRTUj9zF-MiYKpdQdmfGS55yX5Zwc10c_uADJupG6nmKMOCYLA40pTCZNAX_lAwyDA49DArqkvQs07ZHacW9bm1w4UTDJftt0Jh9gx5hos63PfjcZ7Oi2zr7Ae1heYn9jD-S2hyHi4xUXpKnXzeo127y_vK2eN5lXsswE74TsC8MqLiXDqtIa0aCpJGow3DCjc5ULJWRXglaFlsZg31YgUCthCrEgT5daP7UH7HY-2AOE0-7_AfEDbwpYyA</recordid><startdate>200610</startdate><enddate>200610</enddate><creator>Van Luu, Chinh</creator><creator>Van Chau, Minh</creator><creator>Lee, Jung-Joon</creator><creator>Jung, Sang-Hun</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200610</creationdate><title>Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation</title><author>Van Luu, Chinh ; Van Chau, Minh ; Lee, Jung-Joon ; Jung, Sang-Hun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p547-31d34f6c091440e9988eecec94e8ac1c0c82523534d7a85684ccefb9a3e853c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alkaline Phosphatase - genetics</topic><topic>Alkaline Phosphatase - metabolism</topic><topic>Benzopyrans - chemistry</topic><topic>Benzopyrans - pharmacology</topic><topic>Cell Survival - drug effects</topic><topic>Chromans - chemistry</topic><topic>Chromans - pharmacology</topic><topic>Euphorbiaceae - chemistry</topic><topic>Female</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Hydrogenation</topic><topic>Inhibitory Concentration 50</topic><topic>Magnetic Resonance Spectroscopy - methods</topic><topic>Molecular Structure</topic><topic>NF-kappa B - drug effects</topic><topic>NF-kappa B - genetics</topic><topic>NF-kappa B - metabolism</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Spectrophotometry, Infrared - methods</topic><topic>Time Factors</topic><topic>Transfection</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Luu, Chinh</creatorcontrib><creatorcontrib>Van Chau, Minh</creatorcontrib><creatorcontrib>Lee, Jung-Joon</creatorcontrib><creatorcontrib>Jung, Sang-Hun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Archives of pharmacal research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Luu, Chinh</au><au>Van Chau, Minh</au><au>Lee, Jung-Joon</au><au>Jung, Sang-Hun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation</atitle><jtitle>Archives of pharmacal research</jtitle><addtitle>Arch Pharm Res</addtitle><date>2006-10</date><risdate>2006</risdate><volume>29</volume><issue>10</issue><spage>840</spage><pages>840-</pages><issn>0253-6269</issn><abstract>For the exploration of pharmacophoric moiety of malloapelta B (1) possessing the inhibitory activity of NF-kappaB activation, structural variation of alpha,beta-unsaturated carbonyl motif was attempted. 1 was reduced by catalytic hydrogenation, sodium borohydride, and lithium aluminumhydride. Catalytic hydrogenation with 30 psi or 15 psi of H2 gas of 1 generated 8-butyl-5,7-dimethoxy-2,2-dimethylchroman (2) and 1-(5,7-dimethoxy-2,2-dimethylchroman-8-yl)butan-1-one (3), respectively. Reduction with sodium borohydride occurred at the double bond of alpha,beta-unsaturated ketone of 1 to give 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)butan-1-one (4). Reduction of 1 with lithium aluminumhydride and then quenched with methanol and water produced unexpected products, 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-methoxy-1-butene (5) and 1-(5,7-dimethoxy-2,2-dimethyl-2H-chromen-8-yl)-3-hydroxy-l-butene (6). These are formed from the isomerization of initial product 9 through the continuous conjugate carbocation intermediate 11. Addition of ethylmagnesium bromide and dimethyl malonate anion to 1 gave the conjugate adducts 7 and 8. Ethylmagesium bromide and sodium borohydride reduction unusually gave the conjugate addition due to steric congestion around carbonyl group of 1. Compound 2 exhibits the reduced inhibitory activity against NF-kappaB activation and the others do not show the activity. Therefore alpha,beta-unsaturated carbonyl group of 1 should be important for its inhibitory activity.</abstract><cop>Korea (South)</cop><pmid>17121177</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0253-6269 |
ispartof | Archives of pharmacal research, 2006-10, Vol.29 (10), p.840 |
issn | 0253-6269 |
language | eng |
recordid | cdi_pubmed_primary_17121177 |
source | Springer Link |
subjects | Alkaline Phosphatase - genetics Alkaline Phosphatase - metabolism Benzopyrans - chemistry Benzopyrans - pharmacology Cell Survival - drug effects Chromans - chemistry Chromans - pharmacology Euphorbiaceae - chemistry Female HeLa Cells Humans Hydrogenation Inhibitory Concentration 50 Magnetic Resonance Spectroscopy - methods Molecular Structure NF-kappa B - drug effects NF-kappa B - genetics NF-kappa B - metabolism Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - metabolism Spectrophotometry, Infrared - methods Time Factors Transfection Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - pharmacology |
title | Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A06%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploration%20of%20essential%20structure%20of%20malloapelta%20B%20for%20the%20inhibitory%20activity%20against%20TNF%20induced%20NF-kappaB%20activation&rft.jtitle=Archives%20of%20pharmacal%20research&rft.au=Van%20Luu,%20Chinh&rft.date=2006-10&rft.volume=29&rft.issue=10&rft.spage=840&rft.pages=840-&rft.issn=0253-6269&rft_id=info:doi/&rft_dat=%3Cpubmed%3E17121177%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p547-31d34f6c091440e9988eecec94e8ac1c0c82523534d7a85684ccefb9a3e853c63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/17121177&rfr_iscdi=true |